We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Guidant says even physicians with little experience implanting carotid artery stents are getting excellent results using the devices, according to an FDA-mandated postmarketing study.
Medical aesthetics devices developer Lumenis recently announced that it has received FDA clearance to market its new Aluma skin renewal system in the US.
AtriCure, a medical device company focused on developing, manufacturing and selling innovative surgical devices, recently announced the enrollment and treatment of the first patient in its RESTORE-SR II clinical study for the use of the AtriCure Bipolar Ablation System in a sole-therapy, minimally invasive procedure to treat atrial fibrillation.
SpineMedica, a medical device company currently developing an artificial disc implant called SaluDisc, recently announced the completion of its Series A Private Offering, raising more than $10.6 million, in a little over three months.
A recent study published in the Journal of Hand Surgery, "Results from a degradable TMC joint spacer (Artelon) compared with tendon arthroplasty," finds that electrospun Artelon nanofibers, produced by Artimplant, have been successfully used to coat metal implants.
The new CEO of Merck recently told a group of analysts that the company might enter the device and diagnostics market as a way to increase the company's value.
In a recent response to an FDA Form 483 citing deficiencies in the company's quality system (QS) approaches, Guidant argued that while it is taking these concerns seriously, it believes its QS methods are in compliance with the agency's requirements.
The FDA has approved new glucose monitors from devicemakers Abbott and Medtronic, monitors the companies say will help simplify the process by which diabetic patients check their glucose levels.